Search

everythinglearnresearchcommunity

for

Search:↓

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Colorectal cancer development involves both genetic changes and epigenetic alterations like DNA methylation and microRNA changes.

Targeted cancer therapies often cause serious skin problems that need careful management.

Ginseng may help treat cancer and reduce treatment side effects, but more research is needed.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

Using finasteride with TIP extends time off period for prostate cancer patients.

Men who start losing hair at age 30 may have a lower risk of prostate cancer.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

Dutasteride works better than finasteride for preventing and treating prostate cancer.

New cancer treatments aim to reduce side effects and improve effectiveness.

Analog 23 is a promising compound for prostate cancer treatment.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

The conclusion is that individualized treatment and proper medication use are crucial in men's health, with specific recommendations for ED, BPH, and prostate cancer management.

High levels of ST14 and TMEFF1 proteins in ovarian cancer are linked to worse patient outcomes and may be a new treatment target.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

Higher TGF-β signaling may increase skin cancer risk in organ transplant recipients.

Cedrol may be an effective treatment for colorectal cancer.

Suppressing very long chain fatty acids is linked to skin cancer.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Cancer treatments can cause various eye problems, so eye doctors should know how to diagnose and treat these early.

Photobiomodulation therapy helps manage cancer treatment side effects but needs more research for optimization.

The conclusion is that there might be a link between certain types of baldness and prostate cancer, which could be due to shared hormonal pathways.